Call for Abstracts for the 2016 International Neuroethics Society Annual Meeting

International Neuroethics Society
Sunday, March 27, 2016 - Wednesday, June 01, 2016
Present your research to colleagues from around the world at the 2016 Annual Meeting of the International Neuroethics Society in San Diego, CA, November 10-11, 2016. The Society encourages investigators at all stages of their careers to submit abstracts of both an empirical and philosophical nature related to the field of neuroethics. Acceptance will be based on content, available space, and overall program balance. All oral and poster presentations will take place on Friday, November 11, 2016.

Public Lecture: Perceiving and Deciding: From Single Neurons to Brain Circuits

The University of Chicago
Chicago, IL
Monday, May 16, 2016
For the past half-century, systems neuroscientists have been engaged in a charmingly quixotic quest: to understand sophisticated brain functions such as perception and decision-making by studying 100 billion (or so) nerve cells one at a time! Drawing from three decades of work in his own laboratory, William Newsome, Ph.D., Stanford University, will take us on a no-holds-barred tour of this research progression—including the good, the bad and the ugly. He will close with some educated speculation about what the future holds for brain science.

The Addicted Brain and New Treatment Frontiers: Sixth Annual Aspen Brain Forum

The New York Academy of Sciences
New York, NY
Wednesday, May 18, 2016 - Friday, May 20, 2016
This 2.5-day conference will convene a multidisciplinary group of researchers, clinicians, government and industry representatives, and non-profit leaders to explore the latest scientific advances in the field of addiction, with the end goal of improving treatment. The event will feature sessions and presentations focused on the neural circuitry of addiction, neuroplasticity, the susceptibility of the developing adolescent brain, and new horizons for treatment strategies, and will draw on speakers from the fields of neuroscience, behavioral physiology/medicine, cognitive and clinical neuroimaging, pharmacogenetics, neurobiology, psychology, epigenetics, genetic medicine, criminal justice, policy, and economics.  The conference will conclude with a session dedicated to improving social and government policies so that neuroscience research can be more effectively applied to addiction treatment.

Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

The New York Academy of Sciences
New York, NY
Tuesday, June 21, 2016
Surgery helps millions of Americans overcome illness to live longer, healthier lives. Yet for many of these people, surgery can lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia. These risks are poorly understood and often under-recognized in the clinic. The level of risk to a patient depends on the individual and the surgery. For example, delirium is experienced in 15–80% of surgical patients who, in turn, may have a higher risk of long-term cognitive and functional decline. This one-day meeting will convene leading scientists to discuss the challenges and opportunities to create biomarkers and therapeutics for these vulnerable patients.

Multiple Sclerosis: Diagnostic and Treatment Frontiers

The New York Academy of Sciences
New York, NY
Tuesday, June 28, 2016
Multiple sclerosis (MS)—a disease of the central nervous system—causes damage to the myelin that protects axons in the brain, leading to inflammation and damage and thereby disrupting nerve impulses. Given the widespread prevalence and the disabling effects of this neurological condition, it is critical that diagnostics and treatments for MS continue to improve. This one-day, translational conference will address these issues.

ENCODS 2016: European Neuroscience Conference for Doctoral Students

Helsingør, Denmark
Wednesday, June 29, 2016 - Friday, July 01, 2016
ENCODS believes that open-minded interaction with fellow neuroscientists, and beyond, is key to move the field forward. Therefore, the aim of the ENCODS 2016 is threefold:1. To inspire young scientists to look beyond the boundaries of their own field; 2. To provide an intimate environment where young researchers can interact with both renowned scientists and fellow researchers; 3. To help students develop a skill set that is needed to be a good communicator of science.

Emerging Paradigms in Drug Discovery & Chemical Biology

The New York Academy of Sciences
New York, NY
Tuesday, October 25, 2016
Chemical Biology is changing the face of drug discovery. Over the past decade, chemistry based approaches have facilitated unprecedented advances in our understanding of cell biology and animal physiology, and have proven highly useful for drug discovery, demonstrating success not only in target and mechanism identification, but also in target validation and off-target identification. This symposium will highlight recent advances in on-target and off-target identification of drug-protein interactions in physiologically relevant systems, and will feature talks on the ubiquitin proteasome system, GPCRs, protein lipidation mechanisms, neurobiology, and cancer.

Alzheimer's Disease as a Neurovascular Inflammatory Disorder

The New York Academy of Sciences
New York, NY
Tuesday, December 06, 2016
Alzheimer’s disease (AD) constitutes a significant socioeconomic burden, which will only continue to increase as the global population ages. Significant headway into elucidating disease mechanisms has been made, however this progress has not translated into effective strategies for preventing, treating, or curing this crippling disorder. Emerging research suggests a strong link between brain vascular dysfunction and AD. However, despite mounting evidence for vascular pathology in AD, its role in etiology is hotly debated. As a result, there is a clear need to map the molecular and cellular mechanisms that link vascular disease and AD. This symposium will highlight basic research and clinical science elucidating the mechanisms underlying vascular contributions to cognitive impairment and dementia (VCID).